UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004362
Receipt number R000004357
Scientific Title Comparison of oral morphine depots medicated once a day and twice a day as an induction of pain relief.
Date of disclosure of the study information 2010/10/08
Last modified on 2014/10/08 13:06:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of oral morphine depots medicated once a day and twice a day as an induction of pain relief.

Acronym

Comparison of oral morphine depots medicated once a day and twice a day as an induction of pain relief.

Scientific Title

Comparison of oral morphine depots medicated once a day and twice a day as an induction of pain relief.

Scientific Title:Acronym

Comparison of oral morphine depots medicated once a day and twice a day as an induction of pain relief.

Region

Japan


Condition

Condition

lung cancer

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To compare the efficacy of oral morphine depots medicated once a day and twice a day as an induction of pain relief.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Efficacy of pain relief(during one week after medication)
Frequency of resque drug medication

Key secondary outcomes

Evaluation of side effects


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Control group:oral morpine depot medicated twice a day(during one week after medication)

Interventions/Control_2

Intervention group:oral morpine depot medicated once a day(during one week after medication)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Poorly pain-controlled patients using NSAIDs
Patients with written informed consent before treatment

Key exclusion criteria

Patients without written informed consent.
Patients with severe respiratory failure, bronchial asthma attack, severe hepatic disorder, chronic lung disease followed by heart failure, convulsion, acute alcoholism, a past history of hypersensitivity to morphines or opium alkaloids, and hemorrhagic colitis.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Noboru Hattori

Organization

Hiroshima University Hospital

Division name

respiratory medicine

Zip code


Address

Kasumi1-2-3, Minami-ku, Hiroshima City

TEL

082-257-5198

Email

nhattori@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kazunori Fujitaka

Organization

Hiroshima University Hospital

Division name

respiratory medicine

Zip code


Address

Kasumi1-2-3, Minami-ku, Hiroshima City

TEL

082-257-5198

Homepage URL


Email

fujikazu@hiroshima-u.ac.jp


Sponsor or person

Institute

Department of Molecular and Internal Medicine, Hiroshima University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

広島大学病院(広島県)


Other administrative information

Date of disclosure of the study information

2010 Year 10 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2010 Year 05 Month 17 Day

Date of IRB


Anticipated trial start date

2010 Year 07 Month 01 Day

Last follow-up date

2012 Year 03 Month 01 Day

Date of closure to data entry

2012 Year 04 Month 01 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 10 Month 08 Day

Last modified on

2014 Year 10 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004357


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name